Skip to main content

Ryan W Walker, PhD, MS

Dr. Walker a clinical obesity and type 2 diabetes scientist whose research focuses on elucidating the causes of, and treatments for, obesity, type 2 diabetes and metabolic diseases such as Metabolic dysfunction-associated steatotic liver disease (MASLD). The prevalence of these diseases is astounding, and their complexity requires novel, non-traditional approaches accounting for environmental, genetic and metabolic factors. Dr. Walker has made significant contributions to our understanding of the role of genetic and environmental risk factors on MASLD in children and adults and has studied the effects of dietary excess fructose on metabolic risk for nearly 10 years. His work on true fructose content of foods and beverages was a pivotal component in the implementation of sugar sweetened beverage policy change in California.